Desktop Metal (DM) saw a big dip in the premarket despite last week’s IPO
Desktop Metal (DM) stock price dropped almost 30% to $17.35 during the premarket trading session. There doesn’t appear to be any company’s exclusive update that caused DM’sshare price to drop that much today, and investors may want to take notice of this development. Last week, Burlington-based Desktop Metal Inc. (NYSE: DM) gained public exposure on […]
Let’s find out how Apartment Investment and Management Company (AIV) shares nosedived in the Pre-Market
Apartment Investment and Management Company (NYSE: AIV) shares sunk -72.21% to $11.49 in the pre-market session after revealing separation into two publicly traded companies, Apartment Income REIT Corp. and Aimco. Aimco will continue the growth of its apartment development business and look for other opportunities to create value across the U.S. multifamily sector. On December […]
The key reason why Opiant Pharmaceuticals (NASDAQ: OPNT) share rocketed in the pre-market session
Opiant Pharmaceuticals (NASDAQ: OPNT) stock surged 13.93% to $9.65 in the pre-market trading after the company reported that the Biomedical Applied Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response in the United States, has an additional contribution of up to $3.5 million. To advance OPNT003, nasal nalmefene, […]
Top biotech stock rising above expectations in the pre-market session: Immuron Limited (IMRN)
Immuron Limited (NASDAQ: IMRN) shares leaped 22.29% to 8.56 following no new advances have been announced by Biotech. But the benefit from Immuron undoubtedly represented the continuing confidence of some investors. Usually, investors do not put much emphasis on major profits or losses, for that matter, on no information. On a traditionally low-volume trading day, […]
Keep an eye on this stock: Veru Inc. (NASDAQ: VERU), the constant rise in the late hours
Veru Inc. (NASDAQ: VERU), the stock kept on staying up 16.35% to $11.28 in after-market as the biotech oncology company focusing on the development of novel prostate and breast cancer management medicines, unveils positive Phase 2 clinical trial results for the selected oral, novel selective androgen receptor (AR) targeting agent enobosarm for the treatment of […]
Time to watch: How Timber Pharmaceuticals (TMBR) shares jumped in the AH session
Timber Pharmaceuticals (NYSE: TMBR) rose 23.97% to $1.5 in the after-market session. This stock has wildly shifted this year, with buyers keen to raise stock rates for simple business news or no news at all. Nevertheless, on December 10, 2020, A biopharmaceutical corporation focusing on the production and commercialization of therapies for rare and orphan […]
Keeping tabs on this stock: Seneca Biopharma, Inc. (SNCA) rushed in the after-market trading
Seneca Biopharma, Inc. (Nasdaq: SNCA), shares soared 11.5% to $0.89 in the AH trading session as the biopharmaceutical corporation devoted to producing new therapies for conditions of high medical need, recently published its financial results for the quarter ended 30 September 2020. On September 30, 2020, cash was approximately $12.7 million compared to approximately $15.8 […]
So, that’s why Kezar Life Sciences, Inc. (KZR) stock peaked in the after-hours session
Kezar Life Sciences, Inc. (Nasdaq: KZR), the stock soared 17.65% to $6.5 in the after-hours session following the biotechnology firm disclosed that it was added to the NASDAQ Biotech Index (Nasdaq: NBI), effective before market opening on Monday 21 December 2020. The NASDAQ Biotechnology Index is intended to measure stocks’ success traded on the Nasdaq […]
Is that why GrafTech International (EAF) stock fumbled in the post-marketing session?
GrafTech International (EAF) stock dipped -6.11 to $9.06 in the late hours yesterday. The company revealed that affiliates of Brookfield Asset Management Inc. and Brookfield Business Partners LP, members of the Brookfield consortium, priced an underwritten secondary offering of approximately 8,500,000 shares of GrafTech common stock. This represents an increase of 1,500,000 shares relative to […]
Is that why Caladrius Biosciences, (CLBS) share price dropped in the post-market session
Caladrius Biosciences, (CLBS). Shares dropped -7.59% to $1.34 in the after-market session after it was reported that the agenda for the quarterly Life Sciences Investor Forum is available for public and private companies across the world, as well as investors and industry professionals. Throughout the day, a live company presentation and interactive discussion will be […]
